November 25, 2024

Johnson & Johnson Appoints Shawn Millerick President, Vision Care, Americas Erin Power’s role expanded to lead North America for the company’s Surgical Vision business

NOVEMBER 25, 2024 – Johnson & Johnson announces the appointment of Shawn Millerick as President, Vision Care, Americas, effective November 11, 2024.

Shawn will be responsible for defining strategy and driving growth for Johnson & Johnson’s Vision Care portfolio in North America and LATAM including the world’s leading contact lens family ACUVUE. With a strong focus on accelerating digital transformation, Shawn will collaborate with customers and continue to optimize outcomes for patients and eye care professionals.

"I am thrilled to have Shawn onboard leading our Vision Care business across North America and LATAM. His exceptional leadership and deep expertise will serve as a transformative catalyst for our future growth,” shared Peter Menziuso, Company Group Chairman, Vision, Johnson & Johnson MedTech.

Shawn has extensive expertise in the Vision space bringing strong knowledge regarding commercial strategy and enterprise solutions, as well as broad consumer healthcare experience, OTC marketing, focusing on shopper marketing and category insights.

“It is a privilege to return to the vision sector and join a team dedicated to making a positive impact in people's lives. I am inspired by the journey ahead and the opportunity to contribute to a mission that is also deeply personal to me: Vision Made Possible,” said Shawn.

Additionally, Erin Powers has taken on expanded responsibilities, now leading the Surgical Vision business across both the U.S. and Canada as the Vice President of North America, Surgical Vision. Together, Erin and Shawn will focus on maximizing the growth of our Vision Care and Surgical Vision portfolios and collaborate to capitalize on opportunities, synergies, and Johnson & Johnson’s culture as a unified Vision organization.

Learn More: jjvision.com, follow @JNJVision on Twitter, Johnson & Johnson Vision on LinkedIn, and @JNJVision on Facebook.

Media contacts:
Jamie Hall
Johnson & Johnson
jhall41@its.jnj.com

About Vision at Johnson & Johnson

Johnson & Johnson has a deep legacy in developing transformational new products that improve the health of patients’ eyes. As a global leader in eye-health, we have a bold ambition: Vision Made Possible – and are paving the way for a new future of eye health to support the full spectrum of pediatric, developed and mature eyes. Through cutting-edge innovation, scientific expertise, and advanced technologies, we are revolutionizing the way people see and experience the world. At every step of the eye health journey – from contact lenses and refractive and cataract surgical solutions to investigational gene therapies for retinal diseases – we stand as a trusted partner with the goal of making vision possible for customers and patients. Visit us at jjvision.com, follow @JNJVision on Twitter, Johnson & Johnson Vision on LinkedIn, and @JNJVision on Facebook.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more about our MedTech sector’s global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at https://thenext.jnjmedtech.com. Follow us at @JNJMedTech and on LinkedIn.